Detalhe da pesquisa
1.
Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development.
Circulation;
146(22): 1712-1727, 2022 11 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36441819
2.
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial.
Am Heart J;
264: 163-173, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37364748
3.
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction.
Arterioscler Thromb Vasc Biol;
42(3): 352-361, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35045730
4.
High-Throughput Measure of Mitochondrial Superoxide Levels as a Marker of Coronary Artery Disease to Accelerate Drug Translation in Patient-Derived Endothelial Cells Using Opera Phenix® Technology.
Int J Mol Sci;
25(1)2023 Dec 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38203193
5.
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
Lancet;
397(10279): 1085-1094, 2021 03 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33711294
6.
Combining structured and unstructured data in EMRs to create clinically-defined EMR-derived cohorts.
BMC Med Inform Decis Mak;
21(1): 91, 2021 03 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33685456
7.
Utilizing state-of-the-art "omics" technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease.
Microcirculation;
26(2): e12488, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29956866
8.
Coronary artery disease in the absence of traditional risk factors: a call for action.
Eur Heart J;
42(37): 3822-3824, 2021 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34293105
9.
Construction and optimization of multi-platform precision pathways for precision medicine.
Sci Rep;
14(1): 4248, 2024 02 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38378802
10.
Overcoming cohort heterogeneity for the prediction of subclinical cardiovascular disease risk.
iScience;
26(5): 106633, 2023 May 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37192969
11.
Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease.
Biomolecules;
13(8)2023 07 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37627252
12.
Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort.
Biomolecules;
13(6)2023 05 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37371497
13.
Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
Int J Cardiol;
371: 432-440, 2023 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36179904
14.
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease.
Clin Transl Immunology;
12(11): e1462, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37927302
15.
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review.
J Am Coll Cardiol;
82(13): 1343-1359, 2023 09 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37730292
16.
Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study.
J Am Heart Assoc;
11(12): e025236, 2022 06 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35699184
17.
Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors-A DANAMI-3 substudy.
Front Cardiovasc Med;
9: 945815, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35990971
18.
Biomarker Development in Cardiology: Reviewing the Past to Inform the Future.
Cells;
11(3)2022 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35159397
19.
Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.
J Am Heart Assoc;
11(15): e024818, 2022 08 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35876409
20.
Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.
JACC Cardiovasc Interv;
15(11): 1167-1175, 2022 06 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35680197